Compositions comprising nicotine and a volatile nicotine-miscible substance may be used to create sources of modulated nicotine vapor. The modulation of nicotine vapor may be one of quantity or of perceived physiological impact or a combination of both. The substance should have a volatility somewhat similar to that of nicotine and have a normal boiling point between about 175.degree. C. and about 275.degree. C. These compositions may be placed in the nicotine reservoir of a personal oral nicotine inhaler. Esters are preferred nicotine miscible substances, particularly when substantially flavorless and generally recognized as safe for human consumption. Nicotine and nicotine-miscible substance in a weight/weight ratio between about 0.5 and 40.0 are emplaced in a nicotine reservoir, for example absorbed in a porous polyethylene item, for insertion into the tubular passageway of a smokeless cigarette.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.